more important. For this reason, sarcopenia and SO are important issues in the Korean population. Several studies have attempted to address the prevalence of sarcopenia in Korea ( 12 , 13 ) . However, their results could not be applied to the general population.
In this study, we investigated the prevalence of sarcopenia and SO in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys (KNHANES IV) conducted in 2008 -2009.
M ethods

Study P articipants
This study is based upon the data acquired in the second and third year (2008 -2009 ) of KNHANES IV. KNHANES has been conducted periodically since 1998 to assess the health and nutritional status of the civilian noninstitutionalized population of Korea. KNHANES IV was a crosssectional and nationally representative survey conducted from 2007 to 2009 by the Division of Chronic Disease Surveillance, Korea Centers for Disease Control and Prevention. The overall survey consisted of a health interview survey, a nutrition survey, and a health examination survey. Data were collected via household interviews and by direct standardized physical examinations conducted in specially equipped mobile examination centers. The sampling frame was developed based on the 2005 population and housing census in Korea. Household units were selected by a stratifi ed multistage probability sampling design. KNHANES IV had 264,186 primary sampling units, each of which contained about 60 households. Two hundred sampling frames from primary sampling units were randomly sampled , respectively , in 2008 were assessed for body composition by dual-energy x -ray absorptiometry (DXA). We analyzed the data of 4,486 men and 5,999 women aged 20 years or older. Among them, 962 men and 1,370 women were 65 years or older. All the participants in this survey signed an informed consent form.
Defi nition of S arcopenia and SO
DXA (Hologic Discovery-W; Hologic) was used for the measurement of body composition of the participants. ASM was calculated as the sum of muscle mass in arms and legs, assuming that all nonfat and nonbone tissue is skeletal muscle.
According to the defi nition proposed in previous studies, we used the height-adjusted ASM and body weightadjusted ASM ( 3 , 14 ) . To establish the cutoff value of sarcopenia, the gender-specifi c mean and SD of the ASM/height 2 and ASM/weight × 100 of the young reference group (healthy men and women aged 20 -39 years) were used. To select the healthy reference, those who had any history of specifi c diseases such as diabetes, stroke, coronary artery diseases, thyroid disease, arthritis, tuberculosis, asthma, chronic obstructive lung disease, liver cirrhosis, and any cancer were excluded. Among a total of 3,364 participants age d 20 -39 years, 851 who had any of those history were excluded. Individuals whose height-or weight-adjusted ASM was higher than 1 SD below the gender-specifi c mean for young reference group were considered normal according to each defi nition. Class I sarcopenia was indicated by defi nition in participants whose height-or weight-adjusted ASM was from 1 to 2 SD below the mean for young adults. Class II sarcopenia was indicated by defi nition in participants whose height-or weight-adjusted ASM was below 2 SD ( 14 ) . Obesity was defined as a waist circumference more than or equal to 90 cm for men and more than or equal to 85 cm for women, according to the result of a study that redefi ned the waist circumference cutoff points for central obesity in Korean adults ( 15 ) . SO was considered as the combination of class II sarcopenia and obesity according to each defi nition.
Statistical A nalyses
Statistical analyses were performed using SPSS software for Windows version 18.0 (SPSS Inc . , Chicago, IL). The general characteristics of the young reference group were described with mean and SD . The cutoff values of C lass I and C lass II sarcopenia were calculated according to each defi nition.
The participants were grouped by years of age: 20 -39 (reference group), 40 -49, 50 -59, 60 -69, 70 -79, and more than or equal to 80. Those aged 65 years or older were considered elderly subjects . To describe and compare the characteristics of age groups and the elderly population, we took the stratifi ed and clustered structure of the sample and sampling weights into account with complex sample design. The sampling weights were computed using sampling rate and response rate. To estimate the prevalence of sarcopenia and SO in the elderly population with minimal difference between this sample and the actual population, we conducted standardization by the direct method. Direct method was done by applying the rates of sarcopenia in this representative sample being compared with a standard population ( 16 ) . This method yielded the number of cases that would be expected if the age-specifi c rates in standard population were true for the study population. The population structure in 2005 was used as a standard population. The number of Korean elderly population in 2005 was 1,733,661 for men and 2,632,981 for women, respectively. Logistic regression analysis was used to examine the difference of prevalence with age. Linear regression was used to verify the differences of the mean of height-and weight-adjusted ASM with age. To estimate p for trend, the age group variable was regarded as a continuous variable in the trend analysis. All tests were two-sided , and p < .05 was considered statistically signifi cant.
R esults
Among the young reference group, the mean of heightadjusted ASM was 8.42 kg/m 2 for men and 6.18 kg/m 2 for women, and the mean of weight-adjusted ASM was 35.4 for men and 28.1 for women. The cutoff values of C lass II sarcopenia were determined as 6.58 kg/m 2 for men and 4.59 kg/m 2 for women by the height-adjusted defi nition and 29.1% for men and 23.0% for women by the weightadjusted defi nition ( Table 1 ) .
The characteristics of Korean older population were analyzed using direct standardization ( Table 2 ) . By the heightadjusted defi nition, the prevalence of C lass I and C lass II sarcopenia was 30.8% and 12.4% for older men, respectively, and 10.2% and 0.1% for older women, respectively. The prevalence of SO was low in both sexes by this defi nition. By the weight-adjusted defi nition, the prevalence of C lass I and C lass II sarcopenia was 29.5% and 9.7% for older men, respectively, and 30.3% and 11.8% for older women, respectively. More than 75% of the sarcopenic participants in both sexes also were judged to have central obesity ( Table 2 ) .
The characteristics of sarcopenia according to age groups were analyzed with complex sample design. Height-and weight-adjusted ASM by age is shown in Figure 1 . For men, the levels of both height-and weight-adjusted ASM decreased with age (each p for trend < .001). For women, the height-adjusted ASM did not show the decreasing tendency ( p for trend = .249); the tendency of change in weight-adjusted ASM was similar for men ( p for trend < .001).
In the same fashion, the prevalence of C lass II sarcopenia in men increased with age ( Table 3 ). For men, the prevalence of C lass II sarcopenia in those age d 40 -49 years was 1.8% by the height-adjusted defi nition and 1.6% by the weightadjusted defi nition. The prevalence increased to 18.0% and 25.6% by the height-adjusted and weight-adjusted defi nition, respectively, in participants aged 80 years or older . For women, the prevalence of C lass II sarcopenia by the weightadjusted defi nition increased steeply at ages 50 -59 years ; the prevalence did not change much between the age groups 50 years or older . The prevalence in all age groups was nearly zero by the height-adjusted defi nition ( Table 3 ) .
ASM was strongly correlated with height and body weight in men and women (Data not shown). The correlation coeffi cient between ASM and height was .685 for men, .591 for women , respectively , and the coeffi cient between ASM and body weight was .843 for men and .789 for women. Note: Results are expressed as mean ± SD . Participants with C lass I sarcopenia are those whose height-or weight-adjusted ASM was between mean − 1 SD and mean − 2 SD for gender-specifi c young reference group. Participants with C lass II sarcopenia are those whose height-or weight-adjusted ASM is below mean − 2 SD for gender-specifi c young reference group. ASM = appendicular skeletal muscle mass. Note: Results are calculated from complex sample analysis and standardized by direct method. Results are expressed as means or proportion ( SE ). Participants with C lass I sarcopenia are those whose height-or weight-adjusted ASM is between mean − 1 SD and mean − 2 SD for gender-specifi c young reference group. Participants with C lass II sarcopenia are those whose height-or weightadjusted ASM is below mean − 2SD for gender-specifi c young reference group. Participants with obesity are those whose waist circumference is more than or equal to 90 cm for men and more than or equal to 85 cm for women. Participants with sarcopenic obesity are those who have both C lass II sarcopenia and obesity. ASM = appendicular skeletal muscle mass.
ASM and height-and weight-adjusted ASM w ere analyzed by linear and quadratic model with age. Weightadjusted ASM decreased linearly with age in both genders ( Figure 2 ). ASM and height-adjusted ASM were fi t for quadratic model with age in both genders; based on the derived equations, the age at the highest height-adjusted ASM was 34 for men and 51 for women, respectively.
D is cussion
Presently, the prevalence of sarcopenia and SO was quite different according to gender and defi nitions. The prevalence of sarcopenia increased with age generally in KNHANES IV.
In our study, sarcopenic men and women according to the height-adjusted defi nition were rarely accompanied by obesity. This result refl ects the tendency of Koreans with lower body weight to have lower fat mass as well as lower muscle mass. In a previous study, few of the overweight and none of the obese population were classifi ed as sarcopenic using this defi nition ( 5 ). Most sarcopenic individuals, however, had accompanying obesity using the weight-adjusted defi nition in our study. This result could have refl ected the agerelated increases in body weight and fatness and decrease in fat-free mass shown in other studies ( 17 , 18 ) .
For women, unlike for men, the prevalence was extremely different by the defi nitions used in our study. Height-adjusted Figure 1 . Changes of height-and weight-adjusted appendicular muscle mass for age; ( A ) Height-adjusted ASM, p for trend < .001 (in men) and .249 (in women) . ( B ) Weight-adjusted ASM, p for trend < 0.001 (in men and women). * M eans that there is signifi cant difference from the mean of reference group ( p < .05). ** M ean s that there is signifi cant difference from the mean of reference group ( p < .01). ASM = appendicular skeletal muscle mass ; Ht = height ; Wt = body weight .
ASM did not have a peak at age of 20 -39 years but was slightly elevated at ages 40 -49 years, and the value of height-adjusted ASM in the elderly population was almost the same as in the young reference group. Also, a weak positive correlation was found between age and height-adjusted ASM. Originally, to defi ne sarcopenia, Baumgartner and colleagues ( 3 ) needed to consider the relative muscle mass because absolute muscle mass is correlated with height. The height-adjusted ASM has been regarded as a good index of relative skeletal muscle mass ( 3 ). In our study, however, the height-adjusted Note: Results are expressed as proportion ( SE ) derived from complex sample analysis. p for trend was estimated by the linear regression test. Participants with C lass I sarcopenia are those whose height-or weight-adjusted ASM is between mean − 1 SD and mean − 2 SD for gender-specifi c young reference group. Participants with C lass II sarcopenia are those whose height-or weight-adjusted ASM is below mean − 2 SD for gender-specifi c young reference group. ASM = appendicular skeletal muscle mass. ASM showed poor correlation with age-related muscle mass loss. A recent study involving the Chinese elderly population also reported similar fi ndings, leading the authors to conclude that height-adjusted ASM criteria may not be suitable for diagnosing sarcopenia in the Chinese population ( 19 ) . One explanation could be that the slope for the decline in height with age was much steeper for women than for men (data not shown) while ASM with age showed steeper decline in men than in women. The difference in the mean height between women with 20s and 80 years or older was about 14.5 cm, which is much more than the amount that the height of an individual may decrease with aging. In this reason, height-adjusted ASM had a peak at middle age instead of young age. This was opposed to the assumption that the reference is healthier and more abundant in muscle. In contrast, the values of weight-adjusted ASM decreased with age in our study. Other research emphasized that height-adjusted defi nition should be interpreted carefully because the important role of body fat is not incorporated ( 20 ) . Another study of a Korean population reported that SO defi ned by weight-adjusted defi nition was more closely associated with metabolic syndrome ( 13 ) . There were studies that investigated the association between muscle mass and physical performance ( 14 , 21 , 22 ) . Janssen and colleagues showed reduced skeletal muscle mass evaluated by weightadjusted defi nition is associated with functional impairment and disability ( 14 ) . Another study reported sarcopenic participants evaluated by height-adjusted defi nition have not had lower muscle performance with adjustment for body fat mass ( 22 ) . These suggest that ASM adjusted by body weight may be a more appropriate method in defi ning sarcopenia, especially in the Korean population.
A study from New Mexico ( 3 ) reported that the prevalence of sarcopenia in the participants aged 80 years or older was more than 40%, which is a higher prevalence than presently determined. In another study, the prevalence of sarcopenia in participants in their 70s ( 23 ) was 7.8 % -16% in various method; this prevalence is similar to the prevalence by both defi nitions in Korean men and to the prevalence by the weight-adjusted defi nition in women in our study. A study conducted in a Chinese population ( 24 ) reported that the prevalence of sarcopenia by height-adjusted defi nition in those aged 70 years or older was 12.3% for men and 7.2% for women. For men, the prevalence is almost the same as the presently reported prevalence in the Korean m ale elderly population .
There are some Korean studies that showed the prevalence of sarcopenia in the elderly population ( 12 , 13 ) . They measured skeletal muscle mass by DXA; the prevalence was estimated by height-and weight-adjusted defi nition. In one of these studies ( 12 ) , the prevalence of sarcopenia in those aged 60 years or older was considerably lower than the presently determined Korean prevalence, even though the cutoff value was much higher than our data. Lim and colleagues ( 13 ) defi ned sarcopenia as 1 SD below mean of ASM/he i ght 2 and ASM/ weight instead of 2 SD . Their cutoff values were very similar to our values of C lass I sarcopenia in both defi nitions and both genders. However, the prevalence in their sample was lower than the present Korean data in either defi nitions and in either gender. It could also have been caused by the difference of the samples. The participants in both studies enrolled voluntarily; it is possible that the participants in those studies were comparably healthier than average Korean population.
Our study has some limitations. First, the young population was assigned as a reference group. The age-related change occurs in each individual, not between generations. However , the past data of the older participants could not be collected in our study. Due to the limitation of the crosssectional study like ours, many studies investigating sarcopenia have also regarded the young group as the reference ( 3 , 14 , 23 , 25 ) . Second, this study could not evaluate the function of muscle. The function of skeletal muscle as well as muscle mass is important for sarcopenia in the elderly population ( 26 , 27 ) . The European Working Group on Sarcopenia in Older People suggested conceptual stages of sarcopenia considering both muscle function and mass ( 28 ) . The muscle function needs to be evaluated in later studies. Third, we did not use a more precise method to measure the skeletal muscle mass. More precise measurement techniques , such as computed tomography and magnetic resonance imaging , are themselves limited by their high cost of equipment acquisition and use, limited access to the equipment, and radiation exposure during the procedures ( 29 ) . Most prior studies used DXA and bioelectrical impedance analysis to estimate the skeletal muscle mass; the present DXA data are comparable with these studies. Fourth, we could not use a more precise method to evaluate obesity. A Korean study ( 13 ) used computed tomography for the examination of abdominal obesity. Early studies ( 30 , 31 ) used the fat proportion to evaluate obesity. However , waist circumference is a good surrogate marker for central obesity, and the cut value is well established by international criteria ( 32 ) .
This study has powerful strengths. The data are representative of the entire Korean population. Because we analyzed the data considering sampling weight by complex sample design, the results represent population estimates. Also, to calculate the prevalence in the elderly population, direct standardization was used. Because we could analyze large sample of young population, those who had the possible history of illness to affect skeletal muscle could be excluded for calculation of the cut values.
In conclusion, the prevalence of C lass II sarcopenia in the Korean elderly population is 12.4% for men and 0.1% for women by the height-adjusted definition and 9.7% for men and 11.8% for women by the weight-adjusted defi nition. The prevalence of SO is very low by the heightadjusted defi nition and high among sarcopenic participants by the weight-adjusted defi nition. Because the heightadjusted defi nition, especially in women, does not seem to refl ect the real status of the Korean elderly population , alternative defi nitions like the weight-adjusted defi nition should be applied for the studies of sarcopenia. Moreover, the epidemiologic al status of sarcopenia should be described including the muscle function as well as the muscle mass . 
